SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Clinical trials for SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) explained in plain language.

Never miss a new study

Get alerted when new SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) trials appear

Sign up with your email to follow new studies for SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for rare blood cancer: experimental drug targets mast cell disease

Disease control Recruiting now

This study tests an experimental drug called CGT9486 (bezuclastinib) in 140 people with advanced systemic mastocytosis, a rare and serious disease where too many mast cells build up in the body. The goal is to see if the drug can shrink or control the disease and how safe it is. …

Matched conditions: SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated May 26, 2026 09:21 UTC

SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Get alerted when new SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) trials appear

New hope for rare blood cancer: experimental drug targets mast cell disease